In this report, we have provided a systematic review on the utility of PSMA PET/CT in staging and restaging of RCC and performed a metaanalysis on the detection rate of PSMA PET/CT in staging or evaluation of primary RCC and restaging of metastatic or recurrent RCC. Here, FOLH1 is linked to renal cell carcinoma.